Lakewood-Amedex Biotherapeutics Inc.
LABT· Nasdaq
Quarterly figures for Lakewood-Amedex Biotherapeutics Inc., with source filings when available.
4 quarters. Mar 31, 2025 to Jun 30, 2026. mixed units.
Lakewood-Amedex Biotherapeutics Inc. has filed its 10-Q within 45 to 52 days of period end across its last 2 quarters. Few filings are on file, so the projected window is widened until the pattern is clear.
Lakewood-Amedex Biotherapeutics Inc. · CIK 2079272 · Engraved from SEC EDGAR